| Jan'20 | Oct'19 | Jul'19 | Apr'19 | Jan'19 | Oct'18 | Jul'18 | Apr'18 | Jan'18 | Oct'17 | Jul'17 | Apr'17 | Jan'17 | Oct'16 | Jul'16 | Apr'16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | |||||||||||||||
Net loss | |||||||||||||||
-90,832 | -83,350 | -66,678 | -60,538 | -55,524 | -47,676 | -49,333 | -49,221 | -43,805 | -41,690 | -37,082 | -35,778 | -37,607 | 0 | 0 | 0 |
Adjustments to reconcile net loss to net cash provided by operating activities: | |||||||||||||||
Depreciation and amortization | |||||||||||||||
28,553 | 22,887 | 17,775 | 12,463 | 10,442 | 8,725 | 7,946 | 8,041 | 7,562 | 6,867 | 6,084 | 5,106 | 4,575 | 0 | 0 | 0 |
Accretion of discounts on marketable securities, net | |||||||||||||||
-325 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
Amortization of deferred commissions | |||||||||||||||
9,556 | 8,339 | 7,391 | 6,579 | 5,791 | 5,161 | 4,690 | 4,153 | 4,001 | 3,995 | 3,991 | 4,005 | 4,004 | 0 | 0 | 0 |
Amortization of debt discount and issuance costs | |||||||||||||||
35,922 | 26,360 | 16,961 | 11,818 | 11,605 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Stock-based compensation | |||||||||||||||
81,376 | 74,323 | 66,188 | 58,478 | 52,945 | 47,601 | 41,648 | 35,729 | 29,694 | 24,586 | 19,103 | 13,023 | 9,452 | 0 | 0 | 0 |
Other | |||||||||||||||
1,381 | 0 | 0 | 0 | - | - | - | - | -41 | 49 | -440 | -435 | -355 | 0 | 0 | 0 |
Changes in operating assets and liabilities net of effects from acquisitions: | |||||||||||||||
Accounts receivable | |||||||||||||||
11,154 | 17,029 | 19,626 | 13,402 | 28,493 | 13,944 | 10,981 | 8,966 | 10,710 | 8,189 | 9,434 | 4,266 | 20,041 | 0 | 0 | 0 |
Prepaid expenses and other current assets | |||||||||||||||
16,380 | 6,125 | 7,877 | 2,281 | -410 | 3,123 | 1,567 | 1,733 | 390 | -312 | 2,691 | 3,742 | 4,600 | 0 | 0 | 0 |
Other assets | |||||||||||||||
-9,176 | 5,858 | 4,302 | 1,668 | 3,402 | 1,574 | 1,292 | -75 | 746 | -94 | -419 | 1,198 | 1,136 | 0 | 0 | 0 |
Deferred commissions | |||||||||||||||
26,231 | 22,356 | 19,986 | 17,168 | 15,332 | 11,219 | 9,079 | 6,707 | 5,667 | 4,760 | 4,811 | 4,770 | 4,468 | 0 | 0 | 0 |
Accounts payable | |||||||||||||||
-3,720 | -3,402 | -3,246 | 1,860 | 3,182 | -1,882 | -1,751 | -3,502 | -4,005 | 357 | -1,176 | 121 | 224 | 0 | 0 | 0 |
Accrued expenses and other liabilities | |||||||||||||||
-20,727 | 11,932 | 2,078 | 4,058 | 11,399 | 5,074 | 7,222 | 10,413 | 7,120 | 5,217 | 4,896 | 1,545 | 1,772 | 0 | 0 | 0 |
Deferred revenue | |||||||||||||||
73,673 | 49,901 | 44,740 | 43,910 | 45,752 | 31,585 | 34,882 | 33,894 | 36,072 | 23,520 | 22,519 | 21,106 | 25,888 | 0 | 0 | 0 |
Net cash provided by operating activities | |||||||||||||||
68,156 | 55,350 | 33,537 | 43,593 | 37,436 | 26,291 | 27,449 | 25,319 | 19,626 | 10,887 | 2,885 | -3,786 | -20,955 | 0 | 0 | 0 |
Cash flows from investing activities | |||||||||||||||
Purchases of marketable securities | |||||||||||||||
583,151 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
Maturities of marketable securities | |||||||||||||||
66,363 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
Sale of marketable securities | |||||||||||||||
199,314 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
Acquisitions, net of cash acquired | |||||||||||||||
- | - | - | - | 143,885 | 55,693 | 8,180 | 47,113 | 46,075 | 0 | 0 | 0 | - | - | - | - |
Purchases of property and equipment | |||||||||||||||
11,970 | 12,520 | 10,285 | 9,058 | 7,528 | 5,771 | 5,803 | 4,616 | 4,488 | 4,578 | 4,136 | 4,101 | 4,491 | 0 | 0 | 0 |
Net cash used in investing activities | |||||||||||||||
-637,850 | -391,634 | -396,624 | -151,227 | -330,196 | -238,961 | -174,483 | -51,729 | -50,563 | -50,921 | -49,959 | -10,991 | -11,241 | 0 | 0 | 0 |
Proceeds from issuance of convertible senior notes, net of issuance costs | |||||||||||||||
- | - | - | - | -639 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Proceeds from issuance of common stock, net of underwriting discounts, commissions and offering costs | |||||||||||||||
- | - | - | - | - | - | - | - | - | 21,291 | 162,304 | 161,872 | 137,216 | 0 | 0 | 0 |
Proceeds from the exercise of common stock options | |||||||||||||||
17,781 | 16,885 | 17,063 | 14,008 | 12,964 | 12,554 | 12,927 | 11,268 | 12,500 | 10,272 | 10,058 | 8,401 | 4,252 | 0 | 0 | 0 |
Excess tax benefit from stock-based compensation | |||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 51 | 0 | 0 | 0 |
Proceeds from issuance of common stock for employee stock purchase plan | |||||||||||||||
11,455 | 11,455 | 10,037 | 10,037 | 8,778 | 8,778 | 7,936 | 7,935 | 6,824 | 0 | 0 | 0 | - | - | - | - |
Net cash provided by financing activities | |||||||||||||||
696,655 | 695,759 | 694,929 | 24,045 | 21,103 | 221,046 | 220,577 | 218,141 | 241,941 | 38,436 | 175,471 | 173,384 | 141,569 | 0 | 0 | 0 |
Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||||||||||||
126,961 | 359,475 | 331,842 | -83,589 | -271,657 | 8,376 | 73,543 | 191,731 | 211,004 | -1,598 | 128,397 | 158,607 | 109,373 | 0 | 0 | 0 |
Supplemental disclosure of cash flow data | |||||||||||||||
Cash paid for income taxes | |||||||||||||||
2,294 | 2,438 | 2,257 | 5,132 | 4,910 | 4,738 | 4,417 | 1,504 | 1,314 | 904 | 743 | 418 | 390 | 0 | 0 | 0 |
Interest income received | |||||||||||||||
- | - | - | 0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Supplemental disclosure of non-cash investing and financing activities | |||||||||||||||
Vesting of early exercised stock options | |||||||||||||||
- | - | - | - | 333 | 364 | 2,138 | 2,138 | 2,219 | 2,345 | 657 | 671 | 606 | 0 | 0 | 0 |
Property and equipment included in accounts payable and accrued expenses and other current liabilities | |||||||||||||||
337 | 472 | 503 | 1,420 | 832 | 895 | 684 | 76 | 70 | 35 | 15 | 58 | 84 | 0 | 0 | 0 |
Offering costs included in accounts payable and accrued expenses and other current liabilities | |||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | 0 | - | 0 | 0 | 0 |